Table 1. Characteristics of Patients with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), or Acute Lymphoblastic Leukemia (ALL).
| Characteristic | AML, n = 147 | MDS, n = 27 | ALL, n= 34 |
|---|---|---|---|
| Median age, years (range) |
64 (17-84) | 63 (24-75) | 37 (18-78) |
| Performance Status | |||
| 0-1 | 112 | 1 | 28 |
| 2-4 | 35 | 26 | 6 |
| Cytogenetics, | |||
| Favorable | 8 | 0 | |
| Unfavorable | 51 | 11 | |
| Intermediate | 88 | 16 | |
| Hyperdiploid | 2 | ||
| Hypodiploid | 2 | ||
| Ph+ | 3 | ||
| Other | 27 | ||
| Median white blood cell count (range) ×109/L |
3.8 (0.4-161.0) | 2.6 (0.8-23.9) | 7.8 (0.9-74) |
| Median Hemoglobin, g/dL (range) |
7.8 (3.4-13.1) | 7.4 (2.2-11.0) | 8 (4.0-15) |
| Median Platelets ×109/L (range) |
54 (6-377) | 36 (10-270) | 84 (11-485) |
| LDH (U/L) | 772 (289- 11064) |
474 (254- 2322) |
1020 (352- 15113) |
| FAB classification | |||
| M0-2 | 78 | ||
| M3 | 2 | ||
| M4-5 | 38 | ||
| M6/M7 | 5 | ||
| RARS | 1 | ||
| RAEB | 5 | ||
| RAEB-T | 19 | ||
| CMML | 1 | ||
| L1-L2 | 27 | ||
| L3 | 7 |
Abbreviations: RARS, refractory anemia with ring sideroblasts; RAEB, refractory anemia with excess blasts; RAEB-T, refractory anemia with excess blasts in transformation; CMML, chronic myelomonocytic leukemia.